Molecular genetic changes in alveolar soft part sarcoma

Fetal and Pediatric Pathology

Volumn 18, Issue 6, 1998, Pages 529-543

  Chan, Agnes S ^a   Squire, Jeremy A ^b   Thorner, Paul ^c   Zielenska, Maria ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

alveolar soft part sarcoma; beta tryptase precursor; chromosome 19q 12 13.1; DNA amplification; interphase cytogenetics; representational difference analysis

Indexed keywords

DNA; NUCLEIC ACID; RNA;

ADOLESCENT; ALVEOLAR SOFT PART SARCOMA; ARTICLE; CASE REPORT; CHROMOSOME 1P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DNA SEQUENCE; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MOLECULAR GENETICS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032231867     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/15513819809168805     Document Type: Article

References (49)

1. Lieberman P, Brennan M, Kimmel M, Erlandson R. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 1989;63:1-13. (Pubitemid 19031974)
2. Christopherson M, Foote F, Stewart F. Alveolar soft-part sarcomas: structurallly characteristic tumors of uncertain histogenesis. Cancer 1952;5:100-111.
3. Cullinane C, Thorner PS, Greenberg ML, Ng YK, Kumar M, Squire J. Molecular genetic, cytogenetic, and immunohistochemical characterization of alveolar soft-part sarcoma. Cancer 1992;70:2444-2450.
4. Sciot R, Dal Cin P, De Vos R, et al. Alveolar soft-part sarcoma: evidence for its myogenic origin and for the involvement of 17q25. Histopathology 1993;23:439-444. (Pubitemid 23355981)
5. Miettinen M, Ekfors T. Alveolar soft-part sarcoma: immunohistochemical evidence for muscle cell differentiation. Am J Clin Pathol 1990;93:32-38. (Pubitemid 20038935)
6. Mathew T. Evidence supporting neural crest origin of an alveolar soft part sarcoma: an ultrastructural study. Cancer 1982;50:507-514. (Pubitemid 12097421)
7. Foschini MP, Eusebi V. Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma? Semin Diagn Pathol 1994;11:58-68. (Pubitemid 24092136)
8. Rubnitz JE, Downing JR, Crist WM. Pathobiology and clinical significance of molecular genetic findings in childhood tumors. Adv Pediatr 1998;45:315-336.
9. Echten Jv, Berg Evd, Baarlen Jv, et al. An important role for chromosome 17, band q25, in the histogenesis of alveolar soft part sarcoma. Cancer Genet Cytogenet 1995;82:57-61.
10. Heimann P, Devalck C, Debusscher C, Sariban E, Vamos E. Alveolar soft-part sarcoma: further evidence by FISH for the involvement of chromosome band 17q25. Genes Chromosomes Cancer 1998;23:194-197. (Pubitemid 28402347)
11. Kiuru-Kuhlefelt S, El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M. DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study. Mod Pathol 1998;11:227-231. (Pubitemid 28131530)
12. Sorensen PH, Triche TJ. Gene fusions encoding chimaeric transcription factors in solid tumours. Semin Cancer Biol 1996;7:3-14. (Pubitemid 26132191)
13. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994;54:2837-2840. (Pubitemid 24187757)
14. Thorner P, Squire J, Chilton-MacNeill S, et al. Is the EWS/FLI-1 fusion transcript specific for ewing sarcoma and peripheral primitive neuroectodermal tumor? Am J Pathol 1996;148:1125-1138.
15. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t (l;13) (p36;ql4) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994;54:2869-2872. (Pubitemid 24187765)
16. Boerner S, Squire J, Thorner P, McKenna G, Zielenska M. Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Pediatr Pathol 1994;14:823-832. (Pubitemid 24286749)
17. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
18. Squire JA, Thorner P, Marrano P, et al. Identification of MYCN copy number heterogeneity by direct FISH analysis of neuroblastoma preparations. Mol Diagnosis 1996;1:281-289. (Pubitemid 126736430)
19. Ioannou PA, Amemiya CT, Games J, et al. A new bacteriophage PI-derived vector for the propagation of large human DNA fragments. Nature Genet 1994;6:84-89. (Pubitemid 24191918)
20. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-951. (Pubitemid 23080660)
21. Lisitsyn N, Lisitsina N, Dalbagni G, Barker P. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci USA 1995;92:151-155.
22. Schutte M, da Costa LT, Hahn SA, et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 1995;92:5950-5954.
23. Lisitsyn N, Wigler M. Representational difference analysis in detection of genetic lesions in cancer. Methods Enzymol 1995;254:291-304.
24. Bennicelli JL, Fredericks WJ, Wilson RB, Rauscher F Jr, Barr FG. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 1995;11:119-130.
25. Zucman J, Delattre O, Desmaze C, et al. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t (11;22) translocation breakpoints. Genes Chromosomes Cancer 1992;5:271-277. (Pubitemid 23011196)
26. Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing's sarcoma: an evaluation of 85 cases and remarkable consistency of t (l 1;22) (q24;q12). Cancer Genet Cytogenet 1988;32:229-238.
27. Tonini GP. Neuroblastoma: a multiple biological disease. Eur J Cancer 1993;29 A: 802-804. (Pubitemid 23083604)
28. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-1124. (Pubitemid 14106392)
29. Garson JA, Pemberton LF, Sheppard PW, Varndell IM, Coakham HB, Kemshead JT. N-myc gene expression and oncoprotein characterisation in medulloblastoma. Br J Cancer 1989;59:889-894. (Pubitemid 19155702)
30. Lee WH, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 1984;309:458-460. (Pubitemid 14102451)
31. Nisen PD, Zimmerman KA, Cotter SV, Gilbert F, Alt FW. Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res 1986;46:6217-6222. (Pubitemid 17221759)
32. Slave I, Ellenbogen R, Jung WH, et al. myc gene amplification and expression in primary human neuroblastoma. Cancer Res 1990;50:1459-1463. (Pubitemid 20090455)
33. Garson J, Clayton J, Mclntyre P, Kemshead J. N-myc oncogene amplification in rhabdomyosarcoma at release. Lancet 1986;1:1496. (Pubitemid 16095674)
34. Driman D, Thorner PS, Greenberg ML, Chilton-MacNeill S, Squire J. MYCN gene amplification in rhabdomyosarcoma. Cancer 1994;73:2231-2237. (Pubitemid 24107982)
35. Weith A, Martinsson T, Cziepluch C, et al. Neuroblastoma consensus deletion maps to lp36.1-2. Genes Chromosomes Cancer 1989;1:159-166. (Pubitemid 20094561)
36. Maris JM, White PS, Beltinger CP, et al. Significance of chromosome lp loss of heterozygosity in neuroblastoma. Cancer Res 1995;55:4664-4669.
37. Bomme L, Bardi G, Pandis N, Fenger C, Kronborg O, Heim S. Chromosome abnormalities in colorectal adenomas: two cytogenetic subgroups characterized by deletion of lp and numerical aberrations. Hum Pathol 1996;27:1192-1197. (Pubitemid 26374940)
38. Bieche I, Champeme MH, Matifas F, Cropp CS, Callahan R, Lidereau R. Two distinct regions involved in lp deletion in human primary breast cancer. Cancer Res 1993;53:1990-1994. (Pubitemid 23145715)
39. Simons A, Janssen IM, Suijkerbuijk RF, et al. Isolation of osteosarcomaassociated amplified DNA sequences using representational difference analysis. Genes Chromosomes Cancer 1997;20:196-200. (Pubitemid 27431144)
40. Sakakura C, Mori T, Sakabe T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999;24:299-305. (Pubitemid 29115867)
41. Mairal A, Terrier P, Chibon F, Sastre X, Lecesne A, Aurias A. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet 1999;111:134-138. (Pubitemid 29232862)
42. Chen X, Knauf JA, Gonsky R, et al. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet 1998;63:625-637. (Pubitemid 30418644)
43. van Dekken H, Geelen E, Dinjens WN, et al. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res 1999;59:748-752. (Pubitemid 29076077)
44. Curtis LJ, Li Y, Gerbault-Seureau M, et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 1998;53:42-55. (Pubitemid 28489645)
45. Mirza H, Schmidt VA, Derian CK, Jesty J, Bahou WF. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha-or beta-tryptases. Blood 1997;90:3914-3922. (Pubitemid 27484043)
46. Pallaoro M, Fejzo MS, Shayesteh L, Blount JL, Caughey GH. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16pl3.3. J Biol Chem 1999;274:3355-3362. (Pubitemid 29077172)
47. Chung DC, Brown SB, Graeme-Cook F, et al. Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res 1998;58:3706-3711. (Pubitemid 28376572)
48. Jin Y, Merterns F, Persson B, et al. The reciprocal translocation t (9;16) (q22;pl3) is a primary chromosome abnormality in basal cell carcinomas. Cancer Res 1997;57:404-406. (Pubitemid 27081655)
49. Martinez-Climent JA, Comes AM, Vizcarra E, et al. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis. Cancer Genet Cytogenet 1999;110:111-114. (Pubitemid 29181516)